Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR 4,010.25
-47.90 (-1.18%)
At close: Feb 12, 2026
Sanofi India Market Cap
Sanofi India has a market cap or net worth of 92.36 billion as of February 13, 2026. Its market cap has decreased by -24.78% in one year.
Market Cap
92.36B
Enterprise Value
89.44B
Revenue
19.33B
Ranking
n/a
PE Ratio
25.92
Stock Price
4,010.25
Market Cap Chart
Since March 19, 2001, Sanofi India's market cap has increased from 11.29B to 92.36B, an increase of 718.42%. That is a compound annual growth rate of 8.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 92.36B | -1.99% |
| Dec 31, 2025 | 94.23B | -33.15% |
| Dec 31, 2024 | 140.97B | -24.12% |
| Dec 29, 2023 | 185.79B | 37.91% |
| Dec 30, 2022 | 134.72B | -25.89% |
| Dec 31, 2021 | 181.78B | -5.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 308.78B |
| AstraZeneca Pharma India | 223.86B |
| Jubilant Pharmova | 148.25B |
| Granules India | 140.92B |
| Caplin Point Laboratories | 131.67B |
| Rubicon Research | 130.24B |
| CORONA Remedies | 99.91B |
| Procter & Gamble Health | 91.46B |